Drug
Nisoldipine
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | End Stage Renal Disease | 24 | 22.9 | 23.3 | signal |
| 2 | Economic Problem | 17 | 19.4 | 19.6 | signal |
| 3 | Atelectasis | 9 | 16.3 | 16.4 | signal |
| 4 | Nephropathy | 8 | 15.0 | 15.1 | signal |
| 5 | Coronary Artery Disease | 25 | 14.4 | 14.7 | signal |
| 6 | Anhedonia | 21 | 13.9 | 14.1 | signal |
| 7 | Cardiomegaly | 9 | 12.7 | 12.8 | signal |
| 8 | Mitral Valve Incompetence | 8 | 12.4 | 12.5 | signal |
| 9 | Arteriosclerosis | 6 | 11.2 | 11.2 | signal |
| 10 | Chronic Kidney Disease | 46 | 10.5 | 10.9 | signal |
| 11 | Renal Injury | 16 | 9.3 | 9.5 | signal |
| 12 | Myocardial Ischaemia | 6 | 9.2 | 9.2 | signal |
| 13 | Transient Ischaemic Attack | 17 | 8.8 | 8.9 | signal |
| 14 | Cardiac Failure Congestive | 40 | 8.7 | 8.9 | signal |
| 15 | Fluid Overload | 7 | 8.3 | 8.4 | signal |
| 16 | Feeling Jittery | 9 | 8.3 | 8.3 | signal |
| 17 | Local Swelling | 8 | 7.9 | 8.0 | signal |
| 18 | Injury | 31 | 7.7 | 7.9 | signal |
| 19 | Bone Disorder | 7 | 6.7 | 6.7 | signal |
| 20 | Stevens-johnson Syndrome | 8 | 6.3 | 6.3 | signal |
| 21 | Myocardial Infarction | 54 | 5.4 | 5.6 | signal |
| 22 | Coronary Artery Occlusion | 4 | 5.1 | 5.1 | signal |
| 23 | Drug Administration Error | 9 | 5.1 | 5.1 | signal |
| 24 | Pelvic Pain | 5 | 4.8 | 4.8 | signal |
| 25 | Pharmaceutical Product Complaint | 7 | 4.7 | 4.7 | signal |
| 26 | Multiple Fractures | 4 | 4.2 | 4.2 | signal |
| 27 | Emotional Distress | 26 | 3.8 | 3.8 | signal |
| 28 | Completed Suicide | 17 | 3.5 | 3.6 | signal |
| 29 | Extrapyramidal Disorder | 5 | 3.5 | 3.5 | signal |
| 30 | Skin Burning Sensation | 10 | 2.5 | 2.5 | signal |
| 31 | Wrong Technique In Drug Usage Process | 5 | 2.4 | 2.4 | no signal |
| 32 | Application Site Pruritus | 3 | 2.3 | 2.3 | no signal |
| 33 | Tardive Dyskinesia | 3 | 1.8 | 1.8 | no signal |
| 34 | Bladder Cancer | 4 | 1.2 | 1.2 | no signal |